Company · CIK 1829802 # Faeth Therapeutics, Inc. Source: SEC EDGAR · as of 2026-10-27 06:30 UTC · latest filing day 2026-10-26 | CIK | [1829802](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001829802) (SEC EDGAR) | | --- | --- | | Industry (SIC) | 2834 — Pharmaceutical Preparations | | Incorporated in | DE | | Business address | TX | | Listed | FTH (Nasdaq) | | First annual or quarterly report | 2021-03-30 | ## Offerings 4 registrations | Registration | Label and status | First filed | Last event | Filings | | --- | --- | --- | --- | --- | | 333-296894 | Shelf Effective | 2026-06-18 | 2026-06-18 | 1 | | 333-295362 | Shelf Effective | 2026-04-28 | 2026-06-12 | 2 | | 333-263567 | Shelf Effective | 2022-03-15 | 2023-08-17 | 4 | | 333-252138 | IPO Final prospectus | 2021-01-15 | 2021-02-04 | 4 | ## Filings 12 | Filed | Filing | Registration | Accession | | --- | --- | --- | --- | | 2026-06-18 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1829802/000119312526275791/0001193125-26-275791-index.htm) Shelf registered | 333-296894 | 0001193125-26-275791 | | 2026-06-12 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1829802/999999999526001978/9999999995-26-001978-index.htm) Declared effective | 333-295362 | 9999999995-26-001978 | | 2026-04-28 | [S-3](https://www.sec.gov/Archives/edgar/data/1829802/000119312526183535/0001193125-26-183535-index.htm) Shelf registered | 333-295362 | 0001193125-26-183535 | | 2023-08-17 | [424B5](https://www.sec.gov/Archives/edgar/data/1829802/000119312523215140/0001193125-23-215140-index.htm) Shelf takedown | 333-263567 | 0001193125-23-215140 | | 2022-05-09 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1829802/999999999522001367/9999999995-22-001367-index.htm) Declared effective | 333-263567 | 9999999995-22-001367 | | 2022-05-09 | [424B5](https://www.sec.gov/Archives/edgar/data/1829802/000119312522145041/0001193125-22-145041-index.htm) Shelf takedown | 333-263567 | 0001193125-22-145041 | | 2022-03-15 | [S-3](https://www.sec.gov/Archives/edgar/data/1829802/000119312522076072/0001193125-22-076072-index.htm) Shelf registered | 333-263567 | 0001193125-22-076072 | | 2021-02-04 | [424B4](https://www.sec.gov/Archives/edgar/data/1829802/000119312521028832/0001193125-21-028832-index.htm) Final prospectus | 333-252138 | 0001193125-21-028832 | | 2021-02-03 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1829802/999999999521000416/9999999995-21-000416-index.htm) Declared effective | 333-252138 | 9999999995-21-000416 | | 2021-02-01 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1829802/000119312521023615/0001193125-21-023615-index.htm) Amendment | 333-252138 | 0001193125-21-023615 | | 2021-01-15 | [S-1](https://www.sec.gov/Archives/edgar/data/1829802/000119312521010054/0001193125-21-010054-index.htm) Registration filed | 333-252138 | 0001193125-21-010054 | | 2020-11-12 | [DRS](https://www.sec.gov/Archives/edgar/data/1829802/000095012320011480/0000950123-20-011480-index.htm) Draft made public | 377-03775 | 0000950123-20-011480 | [All filings of this company](https://equitycapital.markets/filings?cik=1829802) · [CSV](https://equitycapital.markets/filings.csv?cik=1829802) --- Source page: https://equitycapital.markets/company/1829802 · Data: U.S. SEC EDGAR · CC BY 4.0